Medicine & Health

A team led by WashU Medicine radiology associate professor Shuo Wang has identified neurons that appear to play a key role in our ability to recognize people.

WashU Medicine researchers have identified biomarkers of Alzheimer’s, Parkinson’s and frontotemporal dementia from blood plasma, suggesting new therapeutic avenues.

Biologist Keith Hengen in Arts & Sciences at Washington University in St. Louis says “criticality” is the key to understanding how the brain works — and how to keep it free from Alzheimer’s and other diseases.

The FDA has given market authorization to a WashU startup’s technology that quickly and accurately maps the sensitive areas in patients’ brains to help neurosurgeons plan safe and effective surgeries.

Jennifer Phillips-Cremins, a pioneer in understanding 3D genome structure and its impact on the brain, will join WashU Medicine as BJC Investigator.

Researchers at WashU and St. Jude Children’s Research Hospital have found that biomolecular condensates play a role in suppressing the effects of ALS-causing mutations.

A new study by WashU Medicine researchers suggests that lemborexant and sleep aids that work the same way could help treat or prevent damage caused by harmful buildup of the protein tau in multiple neurodegenerative diseases, including Alzheimer’s.

Researchers at WashU Medicine led by Thomas Papouin have upended the textbook understanding of how connections between brain cells are rearranged during states of heightened vigilance or attention.

A computer scientist at Washington University has developed a problem-solving architecture modeled on neurobiology that leverages quantum mechanical behavior to guarantee optimal solutions to complex problems.

Two WashU faculty are among nearly 250 newly elected members of the American Academy of Arts & Sciences, one of the nation’s most prestigious honorary societies. They are physicist Carl Bender, in Arts & Sciences, and immunologist Marco Colonna, at the School of Medicine.